WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Post-Grant Review

Open PDF
  • Extensive PTAB Experience

    Wilson Sonsini's attorneys have extensive experience before the Patent Trial and Appeal Board, representing clients in numerous new trial proceedings, reexaminations, and patent interference trials.

  • Comprehensive Post-Grant Review Practice

    Wilson Sonsini's team provides services in connection with covered business method review, inter partes review, post-grant review, derivations, and interferences.

  • A Recognized Practice

    Wilson Sonsini's Post-Grant practice has been recognized for its representation of litigants before the PTAB by Managing Intellectual Property magazine and Docket Navigator.

The professionals in Wilson Sonsini's Patent Trial and Appeal Board (PTAB) practice are well suited to navigate the complex trial proceedings at the United States Patent and Trademark Office (USPTO). We have extensive experience before the PTAB, representing clients in numerous new trial proceedings, as well as reexaminations and patent interference trials.

Our practice includes professionals with decades of experience at the PTAB, including former PTAB personnel. Our core team leverages firmwide intellectual property expertise to provide comprehensive IP solutions for clients that cover strategy, prosecution, licensing, enforcement, and defense. When there is concurrent infringement litigation, our PTAB litigation team coordinates seamlessly with our other litigators.

Responding to Change

The America Invents Act (AIA), signed into law in 2011, created four fast-track trial proceedings at the USPTO: covered business method review (CBM), inter partes review (IPR), post-grant review (PGR), and derivations. The PTAB administers each of these new trials, as well as legacy trials, particularly patent interferences (for patents and patent applications with effective filing dates prior to March 16, 2013).

An intricate web of administrative rules, practice guidelines, and decisional law governs PTAB trials. Trials are designed to ensure that all discovery, briefing, and oral arguments are completed within nine months. The PTAB must issue a final written decision within one year from the date trial is instituted. Given these tight timeframes, a successful strategy for PTAB litigation requires careful planning and execution by experienced practitioners who are well versed in PTAB rules and strategy. Misguided PTAB strategy and/or failure to adhere to these rules have caused needless expense and unfavorable case outcomes.

Full Range of Offerings

Covered Business Method Review. Wilson Sonsini is among the top filers of petitions for CBMs in the country. CBM trials address the patentability for certain business method patents that claim a method or apparatus used in the practice, administration, or management of a financial, product, or service, with the exception of patents directed to technological inventions. A party may not file a petition for a CBM proceeding unless the party, its real party in interest, or its privy has been charged with infringement of the patent. CBM proceedings employ the standards and procedures of a post-grant review, with certain exceptions. 

Wilson Sonsini had one of the earliest CBM cases to reach final decision, resulting in the cancellation of all challenged patent claims, Bloomberg Inc. v. Markets-Alert Pty. Ltd, CBM2013-00005, and obtained the first stay of litigation pending CBM review by the Patent Board, Markets-Alert Pty. Ltd. v. Bloomberg Finance L.P., No. 12-780-GMS, 2013WL 443973 (D. Del. Feb. 5, 2013). Wilson Sonsini also obtained the first U.S. Court of Appeals for the Federal Circuit decision overturning a district court denial of stay pending CBM Review, VirtualAgility, Inc. v. Salesforce.com, Inc., 759 F.3d 1307 (Fed. Cir. 2014). Wilson Sonsini represented Salesforce.com in the CBM proceeding and at the Federal Circuit.

Inter Partes Review. IPRs are trials challenging patents based on prior art patents and printed publications. Any issued U.S. patent, regardless of priority, can be challenged by a third party, but patents issuing on applications filed after March 16, 2013, must go through a nine-month period post-grant to allow for any possible post-grant review. Although the majority of IPRs involve co-pending litigation, a challenger need not have been sued on the patent or threatened with suit to file a petition. If sued on a patent, a party has one year to file its petition with the PTAB after being served with a complaint. A party must file a petition before filing a declaratory judgment action challenging the validity of a claim of a patent. If the PTAB determines that a petition demonstrates a "reasonable likelihood" of prevailing on at least one claim, trial is instituted. The patent owner has an opportunity to respond to the allegations, including optionally amending the patent's claims. Even though the burden of proof is on the petitioner, PTAB statistics indicate that once trial is instituted, in most cases at least some of the challenged claims will be held unpatentable. A final PTAB decision can only be appealed to the U.S. Court of Appeals for the Federal Circuit.

We have extensive experience in IPRs, representing both petitioners and patent owners. Wilson Sonsini has represented numerous petitioners, successfully employing coordinated PTAB and district court litigation strategies in defending against infringement assertions. Wilson Sonsini has also established a tremendous track record defending innovators of key life sciences technologies, including successfully defending all challenged claims of entirely through PTAB trials—an uncommon feat at the PTAB. Ariosa Diagnostics v. Verninata Health, Inc. (IPR2013-00276, 00277).

Post-Grant Review. PGRs are new trial proceedings that apply only to patents issuing from applications filed on or after March 16, 2013, pursuant to the AIA's first-inventor-to-file system. A patent can only be challenged in a PGR during the first nine months after it issues. In contrast to an IPR, which is limited to prior art patents and printed publications, a PGR can advance a challenge on any basis of unpatentability. A PGR may be instituted upon a showing that it is "more likely than not" that at least one challenged claim is unpatentable. As with IPR, the patent owner has an opportunity to respond and may file a motion to amend the patent by substituting new claims. The PTAB will issue a final determination within one year after it institutes trial, and an appeal can only be filed with the Federal Circuit.

Derivations. This new PTAB trial procedure determines whether an inventor who is the first to file an application is the true inventor or had derived the invention from someone who files later. The later-filing applicant must initiate the petition, requesting a derivation proceeding within one year of the first publication of a claim in the first-file application that is the same as the later-filed application's claim. The petition must be supported by substantial evidence of derivation. This new proceeding is an adaptation of derivation motions in interference proceedings, but only applies to applications filed under the first-inventor-to-file regime effective March 16, 2013.

Interferences. Wilson Sonsini's PTAB professionals have unsurpassed experience in patent interferences, a PTAB trial procedure available for applications with effective filing dates prior to March 16, 2013. In an interference, the PTAB determines who was the first to invent the subject matter being claimed among competing patent applications, or applications and patents owned by two or more entities (priority), and may also determine patentability of the involved claims.

Third-Party Recognitions

Wilson Sonsini's Post-Grant practice is nationally recognized as a leader for representing petitioners and patent owners before the Patent Trial and Appeal Board. For the first half of 2016, the firm was ranked by Managing Intellectual Property magazine as the No. 2 law firm acting on behalf of petitioners, and as the No. 4 law firm representing either petitioners or patent owners before the PTAB. Additionally, Wilson Sonsini was ranked No. 8 in Docket Navigator's list of the top law firms and corporate legal departments that represented litigants in 2016 inter partes review (IPR), covered business method (CBM), or post-grant review (PGR) proceedings at the PTAB. Wilson Sonsini partner Michael Rosato was also ranked as the No. 1 attorney in the country for filing the most petitions on behalf of petitioners during the period. In addition, Michael and partner Matt Argenti were named among Docket Navigator's list of top attorneys that represented litigants in 2016 IPR, CBM, or PGR proceedings at the PTAB. Further, Wilson Sonsini was ranked among the top 15 percent of all law firms for IP litigation in the BTI Litigation Outlook 2017 report, based on client feedback from in-depth interviews with corporate counsel at the world's largest companies.

Overview

The professionals in Wilson Sonsini's Patent Trial and Appeal Board (PTAB) practice are well suited to navigate the complex trial proceedings at the United States Patent and Trademark Office (USPTO). We have extensive experience before the PTAB, representing clients in numerous new trial proceedings, as well as reexaminations and patent interference trials.

Our practice includes professionals with decades of experience at the PTAB, including former PTAB personnel. Our core team leverages firmwide intellectual property expertise to provide comprehensive IP solutions for clients that cover strategy, prosecution, licensing, enforcement, and defense. When there is concurrent infringement litigation, our PTAB litigation team coordinates seamlessly with our other litigators.

Responding to Change

The America Invents Act (AIA), signed into law in 2011, created four fast-track trial proceedings at the USPTO: covered business method review (CBM), inter partes review (IPR), post-grant review (PGR), and derivations. The PTAB administers each of these new trials, as well as legacy trials, particularly patent interferences (for patents and patent applications with effective filing dates prior to March 16, 2013).

An intricate web of administrative rules, practice guidelines, and decisional law governs PTAB trials. Trials are designed to ensure that all discovery, briefing, and oral arguments are completed within nine months. The PTAB must issue a final written decision within one year from the date trial is instituted. Given these tight timeframes, a successful strategy for PTAB litigation requires careful planning and execution by experienced practitioners who are well versed in PTAB rules and strategy. Misguided PTAB strategy and/or failure to adhere to these rules have caused needless expense and unfavorable case outcomes.

Full Range of Offerings

Covered Business Method Review. Wilson Sonsini is among the top filers of petitions for CBMs in the country. CBM trials address the patentability for certain business method patents that claim a method or apparatus used in the practice, administration, or management of a financial, product, or service, with the exception of patents directed to technological inventions. A party may not file a petition for a CBM proceeding unless the party, its real party in interest, or its privy has been charged with infringement of the patent. CBM proceedings employ the standards and procedures of a post-grant review, with certain exceptions. 

Wilson Sonsini had one of the earliest CBM cases to reach final decision, resulting in the cancellation of all challenged patent claims, Bloomberg Inc. v. Markets-Alert Pty. Ltd, CBM2013-00005, and obtained the first stay of litigation pending CBM review by the Patent Board, Markets-Alert Pty. Ltd. v. Bloomberg Finance L.P., No. 12-780-GMS, 2013WL 443973 (D. Del. Feb. 5, 2013). Wilson Sonsini also obtained the first U.S. Court of Appeals for the Federal Circuit decision overturning a district court denial of stay pending CBM Review, VirtualAgility, Inc. v. Salesforce.com, Inc., 759 F.3d 1307 (Fed. Cir. 2014). Wilson Sonsini represented Salesforce.com in the CBM proceeding and at the Federal Circuit.

Inter Partes Review. IPRs are trials challenging patents based on prior art patents and printed publications. Any issued U.S. patent, regardless of priority, can be challenged by a third party, but patents issuing on applications filed after March 16, 2013, must go through a nine-month period post-grant to allow for any possible post-grant review. Although the majority of IPRs involve co-pending litigation, a challenger need not have been sued on the patent or threatened with suit to file a petition. If sued on a patent, a party has one year to file its petition with the PTAB after being served with a complaint. A party must file a petition before filing a declaratory judgment action challenging the validity of a claim of a patent. If the PTAB determines that a petition demonstrates a "reasonable likelihood" of prevailing on at least one claim, trial is instituted. The patent owner has an opportunity to respond to the allegations, including optionally amending the patent's claims. Even though the burden of proof is on the petitioner, PTAB statistics indicate that once trial is instituted, in most cases at least some of the challenged claims will be held unpatentable. A final PTAB decision can only be appealed to the U.S. Court of Appeals for the Federal Circuit.

We have extensive experience in IPRs, representing both petitioners and patent owners. Wilson Sonsini has represented numerous petitioners, successfully employing coordinated PTAB and district court litigation strategies in defending against infringement assertions. Wilson Sonsini has also established a tremendous track record defending innovators of key life sciences technologies, including successfully defending all challenged claims of entirely through PTAB trials—an uncommon feat at the PTAB. Ariosa Diagnostics v. Verninata Health, Inc. (IPR2013-00276, 00277).

Post-Grant Review. PGRs are new trial proceedings that apply only to patents issuing from applications filed on or after March 16, 2013, pursuant to the AIA's first-inventor-to-file system. A patent can only be challenged in a PGR during the first nine months after it issues. In contrast to an IPR, which is limited to prior art patents and printed publications, a PGR can advance a challenge on any basis of unpatentability. A PGR may be instituted upon a showing that it is "more likely than not" that at least one challenged claim is unpatentable. As with IPR, the patent owner has an opportunity to respond and may file a motion to amend the patent by substituting new claims. The PTAB will issue a final determination within one year after it institutes trial, and an appeal can only be filed with the Federal Circuit.

Derivations. This new PTAB trial procedure determines whether an inventor who is the first to file an application is the true inventor or had derived the invention from someone who files later. The later-filing applicant must initiate the petition, requesting a derivation proceeding within one year of the first publication of a claim in the first-file application that is the same as the later-filed application's claim. The petition must be supported by substantial evidence of derivation. This new proceeding is an adaptation of derivation motions in interference proceedings, but only applies to applications filed under the first-inventor-to-file regime effective March 16, 2013.

Interferences. Wilson Sonsini's PTAB professionals have unsurpassed experience in patent interferences, a PTAB trial procedure available for applications with effective filing dates prior to March 16, 2013. In an interference, the PTAB determines who was the first to invent the subject matter being claimed among competing patent applications, or applications and patents owned by two or more entities (priority), and may also determine patentability of the involved claims.

Third-Party Recognitions

Wilson Sonsini's Post-Grant practice is nationally recognized as a leader for representing petitioners and patent owners before the Patent Trial and Appeal Board. For the first half of 2016, the firm was ranked by Managing Intellectual Property magazine as the No. 2 law firm acting on behalf of petitioners, and as the No. 4 law firm representing either petitioners or patent owners before the PTAB. Additionally, Wilson Sonsini was ranked No. 8 in Docket Navigator's list of the top law firms and corporate legal departments that represented litigants in 2016 inter partes review (IPR), covered business method (CBM), or post-grant review (PGR) proceedings at the PTAB. Wilson Sonsini partner Michael Rosato was also ranked as the No. 1 attorney in the country for filing the most petitions on behalf of petitioners during the period. In addition, Michael and partner Matt Argenti were named among Docket Navigator's list of top attorneys that represented litigants in 2016 IPR, CBM, or PGR proceedings at the PTAB. Further, Wilson Sonsini was ranked among the top 15 percent of all law firms for IP litigation in the BTI Litigation Outlook 2017 report, based on client feedback from in-depth interviews with corporate counsel at the world's largest companies.

Alerts
PTAB Again Rules in Favor of Broad in CRISPR-Cas9 Patent Dispute
Key Points
News Articles
Jad Mills, Richard Torczon Appointed to PTAB Bar Leadership
On March 20, 2026, Wilson Sonsini partner Jad Mills was elected to the board of directors of the PTAB Bar Association and senior counsel Richard Torczon was appointed to Chair of the organization’s Trials Committee. The PTAB Bar Association is committed to preserving and promoting the professional and ethical standards of lawyers and stakeholders who appear before the Patent Trial and Appeal Board (PTAB).
Newsletters
The PTAB Review – January 2026
The January 2026 issue of The PTAB Review discusses notable developments at the PTAB, including changes to institution procedures, and precedential and informative decisions, explores several appellate decisions relevant to PTAB trials, and examines potential rule changes submitted for comment.
Newsletters
Litigation Trends to Watch in 2026
Entering 2026, Wilson Sonsini litigators see a landscape defined by AI driven disputes, continued tightening of patent review standards, renewed securities and governance litigation, stronger consumer and influencer enforcement, and escalating Telephone Consumer Protection Act (TCPA) exposure—trends that require companies to align legal strategy with technical and operational controls.
Client Highlights
Wilson Sonsini Secures PTAB Institution in Five IPRs Filed for Azurity Pharmaceuticals
On November 19, 2025, Wilson Sonsini obtained a significant milestone for Azurity Pharmaceuticals, with the Patent Trial and Appeal Board (PTAB) instituting inter partes review in all five petitions the firm filed on Azurity’s behalf. The petitions challenge methods and compositions for treating chemotherapy-induced nausea and vomiting. The Board’s institution decisions found a reasonable likelihood that Azurity will prevail on at least one challenged claim in each proceeding and authorized full trials on the grounds raised. The Board’s decisions are a notable milestone in the current PTAB environment, where institution rates have tightened significantly. Three Administrative Patent Judges independently concluded the challenges were reasonably likely to succeed, and the cases will now proceed to the yearlong trial phase. 
Alerts
Patent Office Denial of “Late” Inter Partes Review Petitions Changes Expectations
On June 6, 2025, the acting Director of the U.S. Patent and Trademark Office (USPTO), Coke Morgan Stewart, issued a decision in iRhythm Technologies v. Welch Allyn, Inc.1 that initiates a new basis for discretionary denial of inter partes review (IPR) petitions. The Director denied institution of iRhythm’s IPR petitions because iRhythm had upset Welch Allyn’s settled expectations in the enjoyment of its patents. iRhythm is the first such IPR discretionary denial and raises questions about the scope of this new doctrine and its congruence with judicial and congressional developments.
View All
Insights
Alerts
PTAB Again Rules in Favor of Broad in CRISPR-Cas9 Patent Dispute
Key Points
News Articles
Jad Mills, Richard Torczon Appointed to PTAB Bar Leadership
On March 20, 2026, Wilson Sonsini partner Jad Mills was elected to the board of directors of the PTAB Bar Association and senior counsel Richard Torczon was appointed to Chair of the organization’s Trials Committee. The PTAB Bar Association is committed to preserving and promoting the professional and ethical standards of lawyers and stakeholders who appear before the Patent Trial and Appeal Board (PTAB).
Newsletters
The PTAB Review – January 2026
The January 2026 issue of The PTAB Review discusses notable developments at the PTAB, including changes to institution procedures, and precedential and informative decisions, explores several appellate decisions relevant to PTAB trials, and examines potential rule changes submitted for comment.
Newsletters
Litigation Trends to Watch in 2026
Entering 2026, Wilson Sonsini litigators see a landscape defined by AI driven disputes, continued tightening of patent review standards, renewed securities and governance litigation, stronger consumer and influencer enforcement, and escalating Telephone Consumer Protection Act (TCPA) exposure—trends that require companies to align legal strategy with technical and operational controls.
Client Highlights
Wilson Sonsini Secures PTAB Institution in Five IPRs Filed for Azurity Pharmaceuticals
On November 19, 2025, Wilson Sonsini obtained a significant milestone for Azurity Pharmaceuticals, with the Patent Trial and Appeal Board (PTAB) instituting inter partes review in all five petitions the firm filed on Azurity’s behalf. The petitions challenge methods and compositions for treating chemotherapy-induced nausea and vomiting. The Board’s institution decisions found a reasonable likelihood that Azurity will prevail on at least one challenged claim in each proceeding and authorized full trials on the grounds raised. The Board’s decisions are a notable milestone in the current PTAB environment, where institution rates have tightened significantly. Three Administrative Patent Judges independently concluded the challenges were reasonably likely to succeed, and the cases will now proceed to the yearlong trial phase. 
Alerts
Patent Office Denial of “Late” Inter Partes Review Petitions Changes Expectations
On June 6, 2025, the acting Director of the U.S. Patent and Trademark Office (USPTO), Coke Morgan Stewart, issued a decision in iRhythm Technologies v. Welch Allyn, Inc.1 that initiates a new basis for discretionary denial of inter partes review (IPR) petitions. The Director denied institution of iRhythm’s IPR petitions because iRhythm had upset Welch Allyn’s settled expectations in the enjoyment of its patents. iRhythm is the first such IPR discretionary denial and raises questions about the scope of this new doctrine and its congruence with judicial and congressional developments.
View All
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
Affiliated Programs
PTAB Bar Association 2025 Thought Leader Summit
Wilson Sonsini is a proud sponsor of the PTAB Bar Association 2025 Thought Leader Summit, held on Wednesday, October 8, 2025. This year's event will be offered as a bi-coastal experience, held at the USPTO office in San Jose, California (2:00-5:00pm PT) and the Westin Old Town Alexandria in Alexandria, Virginia (2:00-5:00pm ET).
Affiliated Programs
PTAB Masterclass: Pitfalls and Insights with PTAB Judges
Join SFIPLA and Wilson Sonsini in engaging PTAB Judges Janet Gongola and Ifti Ahmed to learn about the evolving practice before PTAB. Learn from the PTAB bench as they take you through the essentials for practicing in front of PTAB—from basics, trial procedures, and appeals process, to strategic insights for hearings and briefing. This comprehensive program will include insightful tips from the Judges and a robust Q&A session.
Affiliated Programs
Los Angeles Intellectual Property Law Association - Washington in the West
Now in its 30th year, Washington in the West is an MCLE-accredited event featuring sessions for patent and trademark attorneys. Wilson Sonsini is pleased to serve as a sponsor for this event which includes a keynote speech by Mary Fuller, Regional Director of the USPTO’s Silicon Valley Regional Office.
Affiliated Programs
2023 PTAB Bar Association Annual Conference
Wilson Sonsini is a proud sponsor for 2023 PTAB Bar Association Annual Conference, March 8-10, 2023, at the Ritz-Carlton in Washington, D.C. which includes three days of engaging and educational presentations and interactive discussions with practitioners, in-house counsel, patent agents, and members of the bench of Patent Trial Appeal Board (PTAB) on best practices, recent developments, and current policy considerations.
Speaking Engagements
PTAB Masters™ 2022
Wilson Sonsini is proud to support the PTAB Masters™ 2022 program, presented by IPWatchdog®, and co-chaired by Scott McKeown and Gene Quinn from January 24-27. 2022. PTAB Masters™ 2022 program will focus on the Patent Trial and Appeal Board from the viewpoint of both the patent owner and petitioners challenging patents. From the most important issues facing the PTAB and USPTO as an agency, to discretionary denials and parallel litigation, through PTAB trial tactics and strategies, this program will address the real-world issues facing stakeholders by presenting best practices, expert insights, and master level planning.
Events
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
Affiliated Programs
PTAB Bar Association 2025 Thought Leader Summit
Wilson Sonsini is a proud sponsor of the PTAB Bar Association 2025 Thought Leader Summit, held on Wednesday, October 8, 2025. This year's event will be offered as a bi-coastal experience, held at the USPTO office in San Jose, California (2:00-5:00pm PT) and the Westin Old Town Alexandria in Alexandria, Virginia (2:00-5:00pm ET).
Affiliated Programs
PTAB Masterclass: Pitfalls and Insights with PTAB Judges
Join SFIPLA and Wilson Sonsini in engaging PTAB Judges Janet Gongola and Ifti Ahmed to learn about the evolving practice before PTAB. Learn from the PTAB bench as they take you through the essentials for practicing in front of PTAB—from basics, trial procedures, and appeals process, to strategic insights for hearings and briefing. This comprehensive program will include insightful tips from the Judges and a robust Q&A session.
Affiliated Programs
Los Angeles Intellectual Property Law Association - Washington in the West
Now in its 30th year, Washington in the West is an MCLE-accredited event featuring sessions for patent and trademark attorneys. Wilson Sonsini is pleased to serve as a sponsor for this event which includes a keynote speech by Mary Fuller, Regional Director of the USPTO’s Silicon Valley Regional Office.
Affiliated Programs
2023 PTAB Bar Association Annual Conference
Wilson Sonsini is a proud sponsor for 2023 PTAB Bar Association Annual Conference, March 8-10, 2023, at the Ritz-Carlton in Washington, D.C. which includes three days of engaging and educational presentations and interactive discussions with practitioners, in-house counsel, patent agents, and members of the bench of Patent Trial Appeal Board (PTAB) on best practices, recent developments, and current policy considerations.
Speaking Engagements
PTAB Masters™ 2022
Wilson Sonsini is proud to support the PTAB Masters™ 2022 program, presented by IPWatchdog®, and co-chaired by Scott McKeown and Gene Quinn from January 24-27. 2022. PTAB Masters™ 2022 program will focus on the Patent Trial and Appeal Board from the viewpoint of both the patent owner and petitioners challenging patents. From the most important issues facing the PTAB and USPTO as an agency, to discretionary denials and parallel litigation, through PTAB trial tactics and strategies, this program will address the real-world issues facing stakeholders by presenting best practices, expert insights, and master level planning.
Matthew A. Argenti
Partner
Palo Alto
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
  • Litigation
View Profile
Jad Mills
Partner
Seattle
Jad A. Mills is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office under the America Invents Act and related federal court proceedings.
  • Litigation
View Profile
Michael T. Rosato
Partner
Seattle
Michael leads the firm’s practice involving contested proceedings at the USPTO and has extensive experience representing clients before the Patent Trial and Appeal Board.
  • Litigation
View Profile
Lori P. Westin
Partner
San Diego
Dr. Lorelei (Lori) Westin is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. Before joining the firm, Lori served as a federal law clerk for the Honorable John A. Houston in the Southern District of California. She also was a patent agent at Howrey Simon Arnold & White. Prior to Howrey, Lori had extensive experience as a research scientist, serving as a senior research scientist in Advanced Technologies at Nanogen, Inc.; a research associate in the Regulatory Biology Laboratory at the Salk Institute; and a postdoctoral fellow in the Laboratory of Molecular Genetics, CMB, at the Karolinska Institute in Sweden. She is the primary author of numerous scientific and legal publications, and is an inventor on seven issued U.S. patents on microchip and DNA amplification technology.
  • Patents and Innovations
View Profile
Wes Derryberry
Senior Counsel
Washington, D.C.
Wesley Derryberry is senior counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he specializes in intellectual property protection. His practice focuses on patent litigation, patent prosecution, and contested proceedings before the U.S. Patent and Trademark Office. Wes has represented a diverse array of clients ranging from large, publicly traded companies to small start-ups. This work has involved a wide variety of technologies, including software, networking, encryption, electronic devices, financial systems, medical devices, and the mechanical arts.
  • Litigation
View Profile
Talin Gordnia
Senior Counsel
Century City
Talin Gordnia is senior counsel at Wilson Sonsini, where she is a member of the patent litigation practice. Talin focuses on patent infringement and trade secret disputes, and has substantial experience representing plaintiffs and defendants in a variety of complex technology areas including semiconductors, computer networking, consumer electronics, enterprise and security software, cellular standards, artificial intelligence, and medical devices. She has experience handling all aspects of patent infringement suits, from the investigation phase through trial and has handled oral arguments in inter partes reviews before the Patent Trial and Appeal Board, including as first chair. Prior to practicing law, Talin was an electrical engineer for Northrop Grumman where she worked on communication satellite payloads and held a security clearance. Talin draws on her experience as a practicing engineer to understand her clients' technologies and translate them into concepts that resonate with juries and jurists. 
  • Litigation
View Profile
Richard Torczon
Senior Counsel
Washington, D.C.
Richard Torczon is senior counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent litigation practice.
  • Litigation
View Profile
Sonja R. Gerrard
Associate
Seattle
Dr. Sonja Gerrard is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where her practice involves representing clients in proceedings before the Patent Trial and Appeal Board including Inter Partes Review. She has experience representing clients in the life sciences and medical device industries with a particular focus on second- and third-generation sequencing technologies.
  • Litigation
View Profile
Mark A. Hayden
Associate
New York
Mark Hayden is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property litigation with a particular emphasis on representing clients in the life sciences industry. He has significant experience litigating under the Hatch-Waxman Act and has played key roles in fact and expert discovery, depositions, trial, and appellate proceedings.
  • Litigation
View Profile
Patrick M. Medley
Associate
Seattle
Patrick Medley is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he specializes in intellectual property protection. His practice focuses on patent prosecution and contested proceedings before the U.S. Patent and Trademark Office. Patrick has represented companies and institutions in a variety of industries, including software, networking, imaging, electronic devices, pharmaceuticals, and medical devices.
  • Litigation
View Profile
View All
People
Matthew A. Argenti
Partner
Palo Alto
Matt is an experienced patent litigatior with an focus on post-grant review proceedings before the PTAB.
  • Litigation
View Profile
Jad Mills
Partner
Seattle
Jad A. Mills is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office under the America Invents Act and related federal court proceedings.
  • Litigation
View Profile
Michael T. Rosato
Partner
Seattle
Michael leads the firm’s practice involving contested proceedings at the USPTO and has extensive experience representing clients before the Patent Trial and Appeal Board.
  • Litigation
View Profile
Lori P. Westin
Partner
San Diego
Dr. Lorelei (Lori) Westin is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. Before joining the firm, Lori served as a federal law clerk for the Honorable John A. Houston in the Southern District of California. She also was a patent agent at Howrey Simon Arnold & White. Prior to Howrey, Lori had extensive experience as a research scientist, serving as a senior research scientist in Advanced Technologies at Nanogen, Inc.; a research associate in the Regulatory Biology Laboratory at the Salk Institute; and a postdoctoral fellow in the Laboratory of Molecular Genetics, CMB, at the Karolinska Institute in Sweden. She is the primary author of numerous scientific and legal publications, and is an inventor on seven issued U.S. patents on microchip and DNA amplification technology.
  • Patents and Innovations
View Profile
Wes Derryberry
Senior Counsel
Washington, D.C.
Wesley Derryberry is senior counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he specializes in intellectual property protection. His practice focuses on patent litigation, patent prosecution, and contested proceedings before the U.S. Patent and Trademark Office. Wes has represented a diverse array of clients ranging from large, publicly traded companies to small start-ups. This work has involved a wide variety of technologies, including software, networking, encryption, electronic devices, financial systems, medical devices, and the mechanical arts.
  • Litigation
View Profile
Talin Gordnia
Senior Counsel
Century City
Talin Gordnia is senior counsel at Wilson Sonsini, where she is a member of the patent litigation practice. Talin focuses on patent infringement and trade secret disputes, and has substantial experience representing plaintiffs and defendants in a variety of complex technology areas including semiconductors, computer networking, consumer electronics, enterprise and security software, cellular standards, artificial intelligence, and medical devices. She has experience handling all aspects of patent infringement suits, from the investigation phase through trial and has handled oral arguments in inter partes reviews before the Patent Trial and Appeal Board, including as first chair. Prior to practicing law, Talin was an electrical engineer for Northrop Grumman where she worked on communication satellite payloads and held a security clearance. Talin draws on her experience as a practicing engineer to understand her clients' technologies and translate them into concepts that resonate with juries and jurists. 
  • Litigation
View Profile
Richard Torczon
Senior Counsel
Washington, D.C.
Richard Torczon is senior counsel in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patent litigation practice.
  • Litigation
View Profile
Sonja R. Gerrard
Associate
Seattle
Dr. Sonja Gerrard is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where her practice involves representing clients in proceedings before the Patent Trial and Appeal Board including Inter Partes Review. She has experience representing clients in the life sciences and medical device industries with a particular focus on second- and third-generation sequencing technologies.
  • Litigation
View Profile
Mark A. Hayden
Associate
New York
Mark Hayden is an associate in the New York office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property litigation with a particular emphasis on representing clients in the life sciences industry. He has significant experience litigating under the Hatch-Waxman Act and has played key roles in fact and expert discovery, depositions, trial, and appellate proceedings.
  • Litigation
View Profile
Patrick M. Medley
Associate
Seattle
Patrick Medley is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati, where he specializes in intellectual property protection. His practice focuses on patent prosecution and contested proceedings before the U.S. Patent and Trademark Office. Patrick has represented companies and institutions in a variety of industries, including software, networking, imaging, electronic devices, pharmaceuticals, and medical devices.
  • Litigation
View Profile
View All
Related Practices
  • Intellectual Property
  • Patent Litigation
Recent Insights
Alerts
PTAB Again Rules in Favor of Broad in CRISPR-Cas9 Patent Dispute
Key Points
Learn More
News Articles
Jad Mills, Richard Torczon Appointed to PTAB Bar Leadership
On March 20, 2026, Wilson Sonsini partner Jad Mills was elected to the board of directors of the PTAB Bar Association and senior counsel Richard Torczon was appointed to Chair of the organization’s Trials Committee. The PTAB Bar Association is committed to preserving and promoting the professional and ethical standards of lawyers and stakeholders who appear before the Patent Trial and Appeal Board (PTAB).
Learn More
View All
Recent Events
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
Learn More
Affiliated Programs
PTAB Bar Association 2025 Thought Leader Summit
Wilson Sonsini is a proud sponsor of the PTAB Bar Association 2025 Thought Leader Summit, held on Wednesday, October 8, 2025. This year's event will be offered as a bi-coastal experience, held at the USPTO office in San Jose, California (2:00-5:00pm PT) and the Westin Old Town Alexandria in Alexandria, Virginia (2:00-5:00pm ET).
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.